Anti-epileptic drugs increase risk of Alzheimer's and dementia

April 9, 2018, University of Eastern Finland
Credit: University of Eastern Finland

The use of anti-epileptic drugs is associated with an increased risk of Alzheimer's disease and dementia, according to a new study from the University of Eastern Finland and the German Center for Neurodegenerative Diseases, DZNE. Continuous use of anti-epileptic drugs for a period exceeding one year was associated with a 15 percent increased risk of Alzheimer's disease in the Finnish dataset, and with a 30 percent increased risk of dementia in the German dataset.

Some anti-epileptic drugs are known to impair cognitive function, which refers to all aspects of information processing. When the researchers compared different anti-epileptic drugs, they found that the risk of Alzheimer's disease and was specifically associated with drugs that impair cognitive function. These drugs were associated with a 20 percent increased risk of Alzheimer's disease and with a 60 percent increased risk of dementia.

The researchers also found that the higher the dose of a that impairs cognitive function, the higher the risk of dementia. However, other anti-epileptic drugs, i.e. those which do not impair cognitive processing, were not associated with the risk.

"More research should be conducted into the long-term cognitive effects of these drugs, especially among older people," Senior Researcher Heidi Taipale from the University of Eastern Finland says.

Besides epilepsy, anti-epileptic drugs are used in the treatment of neuropathic pain, bipolar disorder and generalised anxiety disorder. This new study is the largest research on the topic so far, and the first to investigate the association in terms of regularity of use, dose and comparing the risk between anti-epileptic drugs with and without cognitive-impairing effects. The results were published in the Journal of the American Geriatrics Society.

The association of anti-epileptic drug use with Alzheimer's disease was assessed in Finnish persons diagnosed with Alzheimer's disease and their controls without the disease. This study is part of the nationwide register-based MEDALZ study, which includes all 70,718 persons diagnosed with Alzheimer's in Finland during 2005-2011 and their 282,862 controls. The association of anti-epileptic drug use with dementia was investigated in a sample from a large German statutory health insurance provider, Allgemeine Ortskrankenkasse (AOK). The dataset includes 20,325 persons diagnosed with dementia in 2004–2011, and their 81,300 controls.

Explore further: Benzodiazepines increase mortality in persons with Alzheimer's disease

More information: Heidi Taipale et al. Use of Antiepileptic Drugs and Dementia Risk-an Analysis of Finnish Health Register and German Health Insurance Data, Journal of the American Geriatrics Society (2018). DOI: 10.1111/jgs.15358

Related Stories

Benzodiazepines increase mortality in persons with Alzheimer's disease

November 20, 2017
Benzodiazepine and related drug use is associated with a 40 percent increase in mortality among persons with Alzheimer's disease, according to a new study from the University of Eastern Finland. The findings were published ...

Long-term proton pump inhibitor use does not increase hip fracture risk among Alzheimer's patients

March 13, 2018
Long-term proton pump inhibitor (PPI) use does not increase the risk of hip fracture among persons with Alzheimer's disease, according to a new study from the University of Eastern Finland. The risk of hip fracture was slightly ...

Opioid analgesics reduce use of antipsychotics in persons with Alzheimer's disease

March 26, 2018
Initiating an opioid analgesic reduced the use of antipsychotics and benzodiazepines in persons with Alzheimer's disease, a recent study from the University of Eastern Finland shows. These drugs are frequently prescribed ...

Antiulcer drugs do not increase risk of Alzheimer's disease

August 7, 2017
The use of proton pump inhibitors does not increase the risk of Alzheimer's disease, shows a recent study from the University of Eastern Finland. Proton pump inhibitors are a type of antiulcer drug that is commonly used among ...

Long-term opioid use does not increase risk of Alzheimer 's disease

October 24, 2017
Opioid use is not associated with an increased risk of Alzheimer's disease, shows a recent study from the University of Eastern Finland. Researchers did not find any risk neither for long-term use nor for higher cumulative ...

Arthritis drugs linked to lower Alzheimer's risk

February 13, 2018
Scientists from the University of Southampton have teamed up with researchers from the University of Oxford to look at whether existing drugs for arthritis have any effect on a person's risk of developing dementia. By looking ...

Recommended for you

Study clarifies ApoE4's role in dementia

September 20, 2018
ApoE4, a protein linked to both Alzheimer's disease and a form of dementia caused by damage of blood vessels in the brain, increases the risk of cognitive impairment by reducing the number and responsiveness of blood vessels ...

Machine learning IDs markers to help predict Alzheimer's

September 19, 2018
Nearly 50 million people worldwide have Alzheimer's disease or another form of dementia. These irreversible brain disorders slowly cause memory loss and destroy thinking skills, eventually to such an extent that self-care ...

Discovery could explain failed clinical trials for Alzheimer's, and provide a solution

September 19, 2018
Researchers at King's College London have discovered a vicious feedback loop underlying brain degeneration in Alzheimer's disease which may explain why so many drug trials have failed. The study also identifies a clinically ...

Air pollution may be linked to heightened dementia risk

September 18, 2018
Air pollution may be linked to a heightened risk of developing dementia, finds a London-based observational study, published in the online journal BMJ Open. The associations found couldn't be explained by factors known to ...

A new approach for finding Alzheimer's treatments

September 11, 2018
Considering what little progress has been made finding drugs to treat Alzheimer's disease, Maikel Rheinstädter decided to come at the problem from a totally different angle—perhaps the solution lay not with the peptide ...

Study prevents cognitive decline in older blacks with memory loss

September 10, 2018
With nearly twice the rate of dementia as whites, blacks are at a higher risk for developing diseases like Alzheimer's, but there has been little research on how to reduce this racial health disparity. A new study in black ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.